Related Experiment Video
Updated: Jul 3, 2026
08:36
Generation of Integration-free Human Induced Pluripotent Stem Cells Using Hair-derived Keratinocytes
Published on: August 20, 2015
Generation of human-induced pluripotent stem cells
In-Hyun Park1, Paul H Lerou, Rui Zhao
1Division of Pediatric Hematology Oncology, Children's Hospital Boston, 300 Longwood Avenue, Boston, Massachusetts 02115, USA.
Nature Protocols
|July 5, 2008
Summary
Induced pluripotent stem (iPS) cells offer a patient-specific alternative to embryonic stem cells, bypassing immune rejection for cell therapies. This protocol details generating iPS cells from human fibroblasts within two months.
Area of Science:
- Stem cell biology
- Regenerative medicine
- Molecular biology
Background:
- Pluripotent stem cells, like embryonic stem cells, are vital for research and potential cell therapies.
- Transplantation rejection of embryonic stem cell-derived tissues hinders clinical application.
- Induced pluripotent stem (iPS) cells offer a solution by providing patient-specific cells, avoiding immune rejection.
Purpose of the Study:
- To describe a protocol for deriving induced pluripotent stem (iPS) cells from human fibroblasts.
- To establish a method for generating patient-specific pluripotent stem cells.
- To enable disease modeling using patient-derived iPS cells.
Main Methods:
- Reprogramming primary human fibroblasts into iPS cells.
- Utilizing retroviral transduction of four transcription factors (Oct4, Sox2, Klf4, Myc).
- Establishing primary human fibroblast cell lines from biopsies.
Main Results:
- Successful derivation of induced pluripotent stem (iPS) cells from human fibroblasts.
- Generation of patient-specific pluripotent stem cells.
- Protocol completion within two months from biopsy.
Conclusions:
- Induced pluripotent stem (iPS) cells provide a promising avenue for patient-specific cell therapies, overcoming immune rejection barriers.
- This protocol facilitates the generation of iPS cells for both therapeutic and disease research applications.
- The two-month timeframe makes iPS cell generation from fibroblasts clinically relevant.
More Related Videos
Related Concept Videos
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.